Evidence map›Paper›PMID 31603413›Full record

ArticleCanadian Urological Association journal = Journal de l'Association des urologues du Canada2019

Management of Advanced Kidney Cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2019.

Sebastien J Hotte, Anil Kapoor, Naveen S Basappa, Georg Bjarnason, Christina Canil, Henry J Conter, Piotr Czaykowski, Jeffrey Graham, Samantha Gray, Daniel Y C Heng and 13 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Cytoreductive stereotactic body radiotherapy (SBRT) and combination SBRT with immune checkpoint inhibitors in metastatic renal cell carcinoma.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2021
    Review
  4. Natural history of untreated kidney cancer.World journal of urology · 2021
    Review
  5. Management of advanced kidney cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2021.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Sebastien J HotteJuravinski Cancer Center, Hamilton, ON, Canada.
Anil KapoorUrologic Research Center for Research & Innovation, McMaster University, Hamilton, ON, Canada.
Naveen S BasappaDepartment of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, AB, Canada.
Georg BjarnasonDivision of Medical Oncology/Hematology, Sunnybrook Odette Cancer Center, University of Toronto, Toronto, ON, Canada.
Christina CanilDivision of Medical Oncology, The Ottawa Hospital Cancer Center and the University of Ottawa, Ottawa, ON, Canada.
Henry J ConterWilliam Osler Health System, Brampton, ON, Canada.
Piotr CzaykowskiCancer Care Manitoba, Winnipeg, MB, Canada.
Jeffrey GrahamCancer Care Manitoba, Winnipeg, MB, Canada.
Samantha GrayDepartment of Oncology, Dalhousie University, Saint John Regional Hospital, St. John, NB, Canada.
Daniel Y C HengDepartment of Medical Oncology, University of Calgary and Tom Baker Cancer Center, Calgary AB, Canada.
Pierre I KarakiewiczDepartment of Surgery, Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada.
Christian KollmannsbergerDivision of Medical Oncology, British Columbia Cancer Agency-Vancouver Cancer Center, and the University of British Columbia, Vancouver, BC, Canada.
Aly-Khan A LalaniJuravinski Cancer Center, Hamilton, ON, Canada.
Scott A NorthDepartment of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, AB, Canada.
François PatenaudeDepartment of Medicine, Hematology Service and Department of Oncology, Sir Mortimer B. Davis Jewish General Hospital and McGill University, Montreal, QC, Canada.
Denis SoulièresDivision of Medical Oncology/Hematology, Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada.
Phillippe VioletteDepartment of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, AB, Canada.
Eric WinquistLondon Health Sciences Center, London, ON, Canada.
Lori A WoodQueen Elizabeth II Health Sciences Centre, Halifax, NS, Canada.
Shaan DudaniDepartment of Medical Oncology, University of Calgary and Tom Baker Cancer Center, Calgary AB, Canada.
Ranjena MaloniThe Kidney Cancer Research Network of Canada, Toronto, ON, Canada.
M Neil ReaumeDivision of Medical Oncology, The Ottawa Hospital Cancer Center and the University of Ottawa, Ottawa, ON, Canada.
Kidney Cancer Research Network of Canada

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID31603413
PMCPMC6788909

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.